SEC-sourced researchBeta

WGS

GeneDx Holdings Corp.

US markets

Data passport

CIK: 0001818331
Exchange: Nasdaq
Business activity: — · SIC 8000
Financial inputs: 6/6
Filing date: Sep 18, 2026
SEC registry record: Operating company

Last updated: Oct 8, 2026, 9:09 AM UTCSEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Chart metric

WGS · Exact amounts and source periods · USD
Period end	Revenue	Filing date
December 2023	202,566,000.0000	Feb 23, 2026
December 2024	305,450,000.0000	Feb 23, 2026
December 2025	427,539,000.0000	Feb 23, 2026

Annual periods · USD

Period end	Revenue	Net income	Operating cash flow	Total assets	Total liabilities	Filing date
December 2025	427,539,000.0000	-21,021,000.0000	33,279,000.0000	523,710,000.0000	215,528,000.0000	Feb 23, 2026
December 2024	305,450,000.0000	-52,286,000.0000	-28,496,000.0000	419,380,000.0000	174,133,000.0000	Feb 23, 2026
December 2023	202,566,000.0000	-175,767,000.0000	-180,147,000.0000	—	—	Feb 23, 2026

Financial inputs behind the calculation

Financial inputs	USD	Period end	Filing date	Form
RevenueRevenueFromContractWithCustomerExcludingAssessedTax	$427.54M	December 2025	Feb 23, 2026	10-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax	$305.45M	December 2024	Feb 23, 2026	10-K
Net incomeNetIncomeLoss	-$21.02M	December 2025	Feb 23, 2026	10-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities	$33.28M	December 2025	Feb 23, 2026	10-K
Total assetsAssets	$523.71M	December 2025	Feb 23, 2026	10-K
Total liabilitiesLiabilities	$215.53M	December 2025	Feb 23, 2026	10-K

New filings

Explore methodology ↗